Data Collection for Patients With Low Grade Ovarian Carcinoma

This study is currently recruiting participants.
Verified March 2014 by M.D. Anderson Cancer Center
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00488878
First received: June 18, 2007
Last updated: March 17, 2014
Last verified: March 2014

June 18, 2007
March 17, 2014
May 2006
May 2034   (final data collection date for primary outcome measure)
Data Collection for Patients with Low Grade Ovarian Carcinoma [ Time Frame: 28 Years ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00488878 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Data Collection for Patients With Low Grade Ovarian Carcinoma
Data Collection for Patients With Low Grade Ovarian Carcinoma

The goal of this psychosocial research study is to collect information on patients with one of the above-mentioned low-grade tumors. Researchers want to maintain these patients' information in a research database to help learn and better understand these tumor types and to help develop better treatments for them.

Low-grade tumors of female organs are considered rare. Because of this, doctors do not know the best treatment for these kinds of tumors. Researchers want to learn more about patients' experience with these types of cancer to help find ways to develop better therapies to treat them.

If you agree to take part in this study, information about your type of cancer, the type of treatment you had or are having, and details about your follow-up care will be entered into a research database. These data will be collected from patients seen at MD Anderson since January, 1950. This information will serve as a basis for research studies about patients with low-grade ovarian tumors.

Your data will mostly come from your MD Anderson medical record. However, information may also be requested from you, your local doctor, or an outside hospital. Information collected from sources other than MD Anderson will be included in your MD Anderson medical record as well as entered into this study's database.

Information may be directly collected from you, if there are additional questions not provided in your medical records, if your information is not complete, or if your information collected from other sources does not match what is in your MD Anderson medical record.

To help ensure confidentiality, the database will be password-protected with access strictly limited to study staff.

This research database will be updated at least once a year to include information about your current treatment and/or follow-up care. This information is usually collected from your MD Anderson medical record, or it may be necessary to contact you directly. This information will be collected indefinitely. If you wish to end your participation in this study, you may request that your data remain in the database or that your information be deleted from the database.

This is an investigational study. Up to 1,000 patients will take part in this study. All will be enrolled at MD Anderson.

Observational
Observational Model: Cohort
Not Provided
Retention:   Samples With DNA
Description:

If patient gives consent, tumor tissue left over from earlier surgery or surgeries that is preserved in wax or on glass slides will be stored in a research tissue bank.

Non-Probability Sample

Department of Gynecologic Oncology or the Department of Gynecologic Medical Oncology at UT MD Anderson Cancer Center in Houston, Texas

  • Ovarian Cancer
  • Peritoneum Tumors
Behavioral: Data Collection
Data collection from ovarian cancer patients seen at M.D. Anderson since January, 1950.
Ovarian Cancer Data Collection
Intervention: Behavioral: Data Collection
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1000
Not Provided
May 2034   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients seen at M.D. Anderson Cancer Center with the following tumor types or diagnosis are eligible for inclusion in this database. This includes patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:

    • Ovarian tumor of low malignant potential,
    • Low-grade serous carcinoma of the ovary,
    • Primary peritoneal tumor of low malignant potential,
    • Low-grade serous carcinoma of the peritoneum,
    • Psammocarcinoma

Exclusion Criteria: None

Female
Not Provided
No
Contact: Lisa Nathan 713-745-3837
United States
 
NCT00488878
2006-0137
No
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Not Provided
Principal Investigator: David Gershenson, MD M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP